Literature DB >> 6373770

Cysteines in the transmembrane region of major histocompatibility complex antigens are fatty acylated via thioester bonds.

J F Kaufman, M S Krangel, J L Strominger.   

Abstract

Exogenous radioactive palmitic acid is incorporated post-translationally into the HLA-B and -DR heavy chains, but not HLA-A heavy chains or -DR light chains of the human B lymphoblastoid cells JY and T51 . Protease digestions localize the label to the transmembrane region of the B7 heavy chain. Both B7 and DR heavy chains have a cysteine in the transmembrane hydrophobic region, while the A2 heavy chain and DR light chains have none. Palmitic acid is covalently linked to these transmembrane cysteines via a thioester bond since: 1) the label is not removed by organic extraction or boiling in sodium dodecyl sulfate and dithiothreitol, but is released at room temperature by methanolic KOH as methyl palmitate, and by hydroxylamine as palmitohydroxamate . 2) The pH sensitivity and kinetics of release by hydroxylamine and Tris are similar to those of palmitoyl-CoA (thioester linkage) and unlike those of methyl palmitate and palmitoyllysophosphatidylcholine ( hydroxyester linkages). 3) Neutral hydroxylamine treatment (but not neutral Tris treatment) generates sites that can be reduced and alkylated in the transmembrane region of B7 heavy chain and to a lesser extent in DR heavy chain. 4) Organic extraction of pronase digests of labeled B7 yields peptides containing palmitate and cysteine (but not serine or threonine) which co-migrate by thin layer chromatography. A population of beta 2-microglobulin molecules not associated with heavy chains is palmitylated , but not via a thioester linkage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373770

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  5-Hydroxytryptamine 4(a) receptor expressed in Sf9 cells is palmitoylated in an agonist-dependent manner.

Authors:  E G Ponimaskin; M F Schmidt; M Heine; U Bickmeyer; D W Richter
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

Review 2.  Acylation of viral and eukaryotic proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

Review 3.  Class I genes and molecules: an update.

Authors:  A M Lew; E P Lillehoj; E P Cowan; W L Maloy; M R van Schravendijk; J E Coligan
Journal:  Immunology       Date:  1986-01       Impact factor: 7.397

4.  Myristoylation and the post-translational acquisition of hydrophobicity by the membrane immunoglobulin heavy-chain polypeptide in B lymphocytes.

Authors:  S Pillai; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence.

Authors:  J A Lopez; D W Chung; K Fujikawa; F S Hagen; E W Davie; G J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 6.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

Review 7.  Modification of proteins with covalent lipids.

Authors:  E N Olson
Journal:  Prog Lipid Res       Date:  1988       Impact factor: 16.195

8.  Mature human eosinophils have the capacity to express HLA-DR.

Authors:  D R Lucey; A Nicholson-Weller; P F Weller
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

9.  Cell-free acylation of rat brain myelin proteolipid protein and DM-20.

Authors:  T Yoshimura; D Agrawal; H C Agrawal
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

10.  Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.

Authors:  S L Bursten; R M Locksley; J L Ryan; D H Lovett
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.